Decision aid for heart failure medication conversations
Part of Heart & circulation clinical trials.
This trial tests a tool that helps you and your doctor talk about heart failure medications during your first clinic visit. It's designed for people with a specific type of heart failure (reduced ejection fraction) to make treatment decisions easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are attending your first in-person visit at a heart function clinic in British Columbia.
- You are between 40 and 85 years old.
- You have heart failure with a weakened pumping ability — a recent test shows your ejection fraction is 40% or less.
- You are not currently receiving dialysis or have advanced kidney disease (eGFR below 30).
- You are not in a long-term care facility, hospice, or receiving palliative care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
This study tests whether remote check-ins via phone or video can help safely increase heart failure medications to target doses. You'll use a device to share weight, blood pressure, and heart rate with your doctor, who will adjust your medicines based on how you're doing.
This study tests if a pharmacist-led education program, using a dashboard, can help people with heart failure take their sacubitril/valsartan medicine as prescribed. If you have heart failure with reduced ejection fraction (HFrEF) and are already on this medication, you may be able to join.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.
This trial tests if sending reminders to doctors can improve care for people with heart failure with reduced pumping function. It aims to help patients get the best treatments.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.